)
Visual
test
Psychemedics
Psychemedics (PMD) investor relations material
Psychemedics Q4 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2024 earnings summary23 Mar, 2025
Executive summary
Psychemedics Corporation specializes in patented hair-based drug testing, serving corporate, school, and government clients in the US and internationally.
2024 revenue declined 11% year-over-year to $19.7 million, mainly due to lower domestic testing volumes.
The company completed a reverse/forward stock split and delisted from Nasdaq, now trading on the OTC Pink Market.
Management believes current liquidity is sufficient for at least 12 months, but no fixed credit lines remain.
Financial highlights
Revenue: $19.7M in 2024, down from $22.1M in 2023 (-11%); US revenue fell 12%, international rose 22%.
Net loss: $(1.9)M in 2024, improved from $(4.2)M in 2023.
Gross profit: $7.1M in 2024, down 16% year-over-year.
Operating loss: $(1.9)M in 2024, improved from $(2.9)M in 2023.
Cash at year-end: $1.4M (down from $2.0M); positive operating cash flow of $929K in 2024.
Outlook and guidance
Management expects current cash and future operating profits to cover working capital and capital expenditures for at least the next year.
No formal revenue or earnings guidance provided; future growth depends on customer acquisition and market conditions.
Assess impact of delisting on stock liquidity.
How does patented method improve drug detection?
Explain the decrease in domestic revenue.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Psychemedics
- Approval sought for stock split, buyout, and delisting to go private and reduce costs.PMD
Proxy Filing2 Dec 2025 - Approval sought for going-private transaction, cashing out small holders and delisting shares.PMDProxy Filing2 Dec 2025
- Proposals seek approval for delisting, deregistration, and cashing out small shareholders at $2.35 per share.PMDProxy Filing2 Dec 2025
- Stockholders to vote on going-private plan, cashing out small holders and delisting from Nasdaq.PMDProxy Filing2 Dec 2025
- Reverse split, delisting, and private placement to cut costs and cash out small holders, pending vote.PMDProxy Filing2 Dec 2025
- Adjournment Proposal is routine; brokers may vote at their discretion, with no broker non-votes.PMDProxy Filing2 Dec 2025
- Q3 2024 revenue fell 9% as net loss narrowed and delisting plans advanced.PMDQ3 202413 Jun 2025
- Q2 2024 revenue fell 15% and net loss widened as delisting aims to cut costs.PMDQ2 202413 Jun 2025
Next Psychemedics earnings date
Q4 20253 Apr, 2026
Psychemedics
Next Psychemedics earnings date
Q4 20253 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage